Patents by Inventor Tania BANERJI

Tania BANERJI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11325886
    Abstract: Amide compounds are disclosed. Also disclosed are pharmaceutical compositions comprising the compounds as well as methods of treating neurodegenerative diseases that involve administering the compounds or pharmaceutical compositions to a subject.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: May 10, 2022
    Assignee: Oregon Health & Science University
    Inventors: Thomas S. Scanlan, James Matthew Meinig, Skylar J. Ferrara, Tapasree Banerji, Tania Banerji
  • Publication number: 20210284599
    Abstract: Amide compounds are disclosed. Also disclosed are pharmaceutical compositions comprising the compounds as well as methods of treating neurodegenerative diseases that involve administering the compounds or pharmaceutical compositions to a subject.
    Type: Application
    Filed: August 14, 2017
    Publication date: September 16, 2021
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. SCANLAN, James Matthew MEINIG, Skylar J. FERRARA, Tapasree BANERJI, Tania BANERJI
  • Patent number: 10870616
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: December 22, 2020
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas Scanlan, Jordan Devereaux, Andrew Placzek, Tapasree Banerji, Skylar Ferrara, James Matthew Meinig, Tania Banerji
  • Publication number: 20200325092
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Application
    Filed: December 9, 2019
    Publication date: October 15, 2020
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas SCANLAN, Jordan DEVEREAUX, Andrew PLACZEK, Tapasree BANERJI, Skylar FERRARA, James Matthew MEINIG, Tania BANERJI
  • Patent number: 10544075
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: January 28, 2020
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas Scanlan, Jordan Devereaux, Andrew Placzek, Tapasree Banerji, Skylar Ferrara, James Matthew Meinig, Tania Banerji
  • Publication number: 20190210950
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Application
    Filed: May 18, 2017
    Publication date: July 11, 2019
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas SCANLAN, Jordan DEVERAUX, Andrew PLACZEK, Tapasree BANERJI, Skylar FERRARA, James Matthew MEINIG, Tania BANERJI